“…a Refs. | Glucose-level prediction | Dexcom G6+ | Interstitial glucose concentration, electrodermal activity, skin temperature, activity | DT | 16 | Yes, at home | 271 |
Dexcom C4, Dexcom C7 plus, Medtronic iPro2 | Glucose concentration | NN | 278 | Yes, with follow-up visits | 272 |
Abbott FreeStyle Libre | Glucose concentration | ARIMA, RF, SVM | 25 | Yes | 273 |
Epilepsy management | Empatica E4 | Motor seizures | DNN-LSTM | 38 | No, in controlled environment | 274 |
Face action, fatigue and drowsiness monitoring | Eyeglass platform with accelerometer, gyroscope and electrooculography sensors | Facial action detection, blinks, percentage of eye closure | CNN, LR | 17 | No, in controlled environment | 275 , 276 |
Parkinson disease | Six Opal IMU sensors | Balance and gait features | NN, SVM, kNN, DT, RF, GB, LR | 524 patients with Parkinson disease and 43 patients with essential tremor | No, in controlled environment | 277 |
Great Lakes NeuroTechnologies wrist and ankle accelerometers | Free movement gyroscope data | Ensemble methods (LSTM, 1D CNN-LSTM, 2D CNN-LSTM) | 24 | No, in controlled environment | 278 |
Mood disorder | Mi Band 2 supported with clinician report, self-report and smartphone use log through app | Daily phone usage, sleep data, step count data, self-evaluated mood scores of the user | SVM, RF, kNN | 334 | Yes, with follow-up visits | 279 |
Respiratory disorders and diseases | Two wireless wearables attached to the chest (non-commercial) | Respiratory behaviours | RF | 11 | No, in controlled ... |
…”